Vaccination of Immunocompromised Cats
Hartmann, Katrin (Ludwig Maximilian University of Munich. Clinic of Small Animal Medicine)
Möstl, Karin (University of Veterinary Medicine. Institute of Virology)
Lloret, Albert (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari)
Thiry, Etienne (Liège University. Veterinary Virology and Animal Viral Diseases)
Addie, Diane D. (University of Glasgow. Veterinary Diagnostic Services)
Belák, Sándor (Swedish University of Agricultural Sciences (SLU). Department of Biomedical Sciences and Veterinary Public Health)
Boucraut-Baralon, Corine (Scanelis Laboratory)
Egberink, Herman (University of Utrecht. Department of Biomolecular Health Sciences)
Frymus, Tadeusz (Warsaw University of Life Sciences. Department of Small Animal Diseases with Clinic)
Hofmann-Lehmann, Regina (University of Zurich. Department of Clinical Diagnostics and Services)
Lutz, Hans (University of Zurich. Department of Clinical Diagnostics and Services)
Marsilio, Fulvio (Università Degli Studi di Teramo. Faculty of Veterinary Medicine)
Pennisi, Maria Grazia (Università di Messina. Dipartimento di Scienze Veterinarie)
Tasker, Séverine (Linnaeus Veterinary Ltd.)
Truyen, Uwe (University of Leipzig. Institute of Animal Hygiene and Veterinary Public Health)
Hosie, Margaret J. (University of Glasgow Centre for Virus Research)

Date:	2022
Abstract:	Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Feline ; Immunocompromise ; Immunosuppression ; Immunodeficiency ; Vaccine ; Efficacy ; Safety ; Duration of immunity ; DOI
Published in:	Viruses, Vol. 14 (april 2022) , ISSN 1999-4915

DOI: 10.3390/v14050923
PMID: 35632665

24 p, 428.5 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Grup de Recerca Malalties infeccioses-inflamatòries en animals de companyia (MIAC)
Articles > Research articles
Articles > Published articles